Mechanistic Insights into Honeybee Propolis as a Natural Modulator of Inflammation and Oxidative Stress: A Narrative Review

Ahlam Omer, Shelan Rasool, Hazhmat Ali

Abstract


Honeybee propolis has been used as a natural remedy for centuries to treat various diseases. This review examines the mechanistic basis of propolis's anti-inflammatory and antioxidant properties, as well as its therapeutic applications. A narrative methodology was utilized, incorporating a comprehensive literature search to identify relevant, high-quality evidence from major biomedical databases. The evidence suggests that propolis exhibits significant anti-inflammatory and antioxidant effects, primarily attributed to its diverse phytochemical composition, including caffeic acid phenethyl ester and flavonoids. These compounds regulate inflammatory signaling pathways, particularly the nuclear factor κB pathway. Furthermore, the bioactive constituents exhibit strong free radical-scavenging activity, supporting the restoration of normal cellular metabolism. Although propolis exhibits significant anti-inflammatory and antioxidant properties, most supporting evidence is derived from in vitro and preclinical studies. The limited availability of clinical data necessitates cautious interpretation of these results. Large-scale clinical trials and standardized formulations are required to establish robust evidence of its efficacy.

Keywords


Honeybee propolis; Anti-inflammatory; Antioxidant; Therapeutic potential; Flavonoids; Caffeic acid

Full Text:

PDF

References


N. Zullkiflee, H. Taha, and A. Usman, “Propolis: Its role and efficacy in human health and diseases,” Molecules, vol. 27, no. 18, art. no. 6120, 2022. [Online]. Available: https://doi.org/10.3390/molecules27186120

T. Nagai, R. Inoue, H. Inoue, and N. Suzuki, “Preparation and antioxidant properties of water extract of propolis,” Food Chemistry, vol. 80, no. 1, pp. 29–33, 2003. [Online]. Available: https://doi.org/10.1016/S0308-8146(02)00231-5

R. Hossain, C. Quispe, R. A. Khan, A. S. M. Saikat, P. Ray, D. Ongalbek, et al., “Propolis: An update on its chemistry and pharmacological applications,” Chinese Medicine, vol. 17, art. no. 100, 2022. [Online]. Available: https://doi.org/10.1186/s13020-022-00651-2

T. Ozdal, F. D. Ceylan, N. Eroglu, M. Kaplan, E. O. Olgun, and E. Capanoglu, “Investigation of antioxidant capacity, bioaccessibility and LC-MS/MS phenolic profile of Turkish propolis,” Food Research International, vol. 122, pp. 528–536, 2019. [Online]. Available: https://doi.org/10.1016/j.foodres.2019.05.028

C. C. Fernandes-Silva, J. C. Freitas, A. Salatino, and M. L. F. Salatino, “Cytotoxic activity of six samples of Brazilian propolis on sea urchin (Lytechinus variegatus) eggs,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, art. no. 619361, 2013. [Online]. Available: https://doi.org/10.1155/2013/619361

J. Cvek, M. Medić-Šarić, D. Vitali, I. Vedrina-Dragojević, Z. Šmit, and S. Tomić, “The content of essential and toxic elements in Croatian propolis samples and their tinctures,” Journal of Apicultural Research, vol. 47, no. 1, pp. 35–45, 2008. [Online]. Available: https://www.tandfonline.com/doi/abs/10.1080/00218839.2008.11101424

M. A. Cantarelli, J. M. Camiña, E. Pettenati, E. J. Marchevsky, and R. G. Pellerano, “Trace mineral content of Argentinean raw propolis by neutron activation analysis (NAA): Assessment of geographical provenance by chemometrics,” LWT - Food Science and Technology, vol. 44, no. 1, pp. 256–260, 2011. [Online]. Available: https://doi.org/10.1016/j.lwt.2010.06.031

A. K. Kuropatnicki, E. Szliszka, and W. Król, “Historical aspects of propolis research in modern times,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, art. no. 964149, 2013. [Online]. Available: https://doi.org/10.1155/2013/964149

A. Gholami, N. Dinarvand, and M. Hariri, “Propolis supplementation can reduce serum level of interleukin-6, C-reactive protein, and tumor necrosis factor-α: An updated systematic review and dose-response meta-analysis on randomized clinical trials,” Journal of Health, Population and Nutrition, vol. 43, art. no. 119, 2024. [Online]. Available: https://doi.org/10.1186/s41043-024-00600-9

S. Adeli, M. Maroofi, F. P. F. Tabrizi, B. Alipour, M. Heidari, et al., “Effects of propolis consumption on glycemic indices and liver enzymes in adults: A GRADE-assessed systematic review and dose-response meta-analysis,” Clinical Therapeutics, vol. 46, no. 9, pp. e6–e14, 2024. [Online]. Available: https://doi.org/10.1016/j.clinthera.2024.06.022

S. Silici and S. Kutluca, “Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 69–73, 2005. [Online]. Available: https://doi.org/10.1016/j.jep.2005.01.046

M. A.-H. Ballouk, M. Altinawi, and P. S. Fudalej, “The multifaceted therapeutic potential of propolis: An integrative report on its pharmacological properties and emerging advances,” Discover Applied Sciences, vol. 7, art. no. 21, 2025. [Online]. Available: https://doi.org/10.1007/s42452-025-07648-0

M. Franchin, I. A. Freires, J. G. Lazarini, B. D. Nani, M. G. da Cunha, D. F. Colón, et al., “The use of Brazilian propolis for discovery and development of novel anti-inflammatory drugs,” European Journal of Medicinal Chemistry, vol. 153, pp. 49–55, 2018. [Online]. Available: https://doi.org/10.1016/j.ejmech.2017.06.050

S. De Marco, M. Piccioni, R. Pagiotti, and D. Pietrella, “Antibiofilm and antioxidant activity of propolis and bud poplar resins versus Pseudomonas aeruginosa,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, art. no. 5163575, 2017. [Online]. Available: https://doi.org/10.1155/2017/5163575

B. Bueno-Silva, M. Franchin, C. F. Alves, C. Denny, D. F. Colón, T. M. Cunha, S. M. Alencar, M. H. Napimoga, and P. L. Rosalen, “Main pathways of action of Brazilian red propolis on the modulation of neutrophil migration in the inflammatory process,” Phytomedicine, vol. 23, no. 13, pp. 1583–1590, 2016. [Online]. Available: https://doi.org/10.1016/j.phymed.2016.09.009

N. Steinckwich, J.-P. Frippiat, M.-J. Stasia, M. Erard, R. Boxio, C. Tankosic, et al., “Potent inhibition of store-operated Ca²⁺ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2,” Journal of Leukocyte Biology, vol. 81, no. 4, pp. 1054–1064, 2007. [Online]. Available: https://doi.org/10.1189/jlb.0406248

M. Zakerkish, M. Jenabi, N. Zaeemzadeh, A. A. Hemmati, and N. Neisi, “The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double-blind clinical trial,” Scientific Reports, vol. 9, art. no. 7289, 2019. [Online]. Available: https://doi.org/10.1038/s41598-019-43838-8

V. Mujica, R. Orrego, R. Fuentealba, E. Leiva, and J. Zúñiga-Hernández, “Propolis as an adjuvant in the healing of human diabetic foot wounds receiving care in the Diagnostic and Treatment Centre from the Regional Hospital of Talca,” Journal of Diabetes Research, vol. 2019, art. no. 2507578, 2019. [Online]. Available: https://doi.org/10.1155/2019/2507578

N. Pahlavani, M. Malekahmadi, S. Firouzi, D. Rostami, A. Sedaghat, A. B. Moghaddam, et al., “Molecular and cellular mechanisms of the effects of propolis in inflammation, oxidative stress and glycemic control in chronic diseases,” Nutrition & Metabolism, vol. 17, art. no. 65, 2020. [Online]. Available: https://doi.org/10.1186/s12986-020-00485-5

F. Armutcu, S. Akyol, S. Ustunsoy, and F. F. Turan, “Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects: A review,” Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1582–1588, 2015. [Online]. Available: https://doi.org/10.3892/etm.2015.2346

M.-S. Cho, W.-S. Park, W.-K. Jung, Z.-J. Qian, D.-S. Lee, J.-S. Choi, et al., “Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells,” Pharmaceutical Biology, vol. 52, no. 7, pp. 926–932, 2014. [Online]. Available: https://doi.org/10.3109/13880209.2013.865243

L. Li, W. Sun, T. Wu, R. Lu, and B. Shi, “Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway,” European Journal of Pharmacology, vol. 794, pp. 61–68, 2017. [Online]. Available: https://doi.org/10.1016/j.ejphar.2016.11.003

L. Cornara, M. Biagi, J. Xiao, and B. Burlando, “Therapeutic properties of bioactive compounds from different honeybee products,” Frontiers in Pharmacology, vol. 8, art. no. 412, 2017. [Online]. Available: https://doi.org/10.3389/fphar.2017.00412

M. Funakoshi-Tago, K. Okamoto, R. Izumi, K. Tago, K. Yanagisawa, Y. Narukawa, F. Kiuchi, T. Kasahara, et al., “Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway,” International Immunopharmacology, vol. 25, no. 1, pp. 189–198, 2015. [Online]. Available: https://doi.org/10.1016/j.intimp.2015.01.012

V. Zaccaria, V. Curti, A. Di Lorenzo, A. Baldi, C. Maccario, S. Sommatis, et al., “Effect of green and brown propolis extracts on the expression levels of microRNAs, mRNAs and proteins related to oxidative stress and inflammation,” Nutrients, vol. 9, no. 10, art. no. 1090, 2017. [Online]. Available: https://doi.org/10.3390/nu9101090

S. A. de Moura, M. A. Ferreira, S. P. Andrade, M. L. Reis, M. de L. Noviello, and D. C. Cara, “Brazilian green propolis inhibits inflammatory angiogenesis in a murine sponge model,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, art. no. 182703, 2011. [Online]. Available: https://doi.org/10.1093/ecam/nep197

A. P. Tiveron, P. L. Rosalen, M. Franchin, R. C. Lacerda, B. Bueno-Silva, B. Benso, C. Denny, M. Ikegaki, and S. M. Alencar, “Chemical characterization and antioxidant, antimicrobial, and anti-inflammatory activities of South Brazilian organic propolis,” PLOS ONE, vol. 11, no. 11, art. no. e0165588, 2016. [Online]. Available: https://doi.org/10.1371/journal.pone.0165588

N. Paulino, S. R. Abreu, Y. Uto, D. Koyama, H. Nagasawa, H. Hori, et al., “Anti-inflammatory effects of a bioavailable compound, artepillin C, in Brazilian propolis,” European Journal of Pharmacology, vol. 587, no. 1–3, pp. 296–301, 2008. [Online]. Available: https://doi.org/10.1016/j.ejphar.2008.02.067

J. L. Machado, A. K. Assunção, M. C. da Silva, A. S. dos Reis, G. C. Costa, D. de S. Arruda, et al., “Brazilian green propolis: Anti-inflammatory property by an immunomodulatory activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, art. no. 157652, 2012. [Online]. Available: https://doi.org/10.1155/2012/157652

J. B. Daleprane, V. da S. Freitas, A. Pacheco, M. Rudnicki, L. A. Faine, F. A. Dörr, et al., “Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis,” Journal of Nutritional Biochemistry, vol. 23, no. 6, pp. 557–566, 2012. [Online]. Available: https://doi.org/10.1016/j.jnutbio.2011.02.012

I. Przybyłek and T. M. Karpiński, “Antibacterial properties of propolis,” Molecules, vol. 24, no. 11, art. no. 2047, 2019. [Online]. Available: https://doi.org/10.3390/molecules24112047

R. Bridi, G. Montenegro, G. Nuñez-Quijada, A. Giordano, M. F. Morán-Romero, I. Jara-Pezoa, et al., “International regulations of propolis quality: Required assays do not necessarily reflect their polyphenolic-related in vitro activities,” Journal of Food Science, vol. 80, no. 6, pp. C1188–C1195, 2015. [Online]. Available: https://doi.org/10.1111/1750-3841.12881

V. C. Toreti, H. H. Sato, G. M. Pastore, and Y. K. Park, “Recent progress of propolis for its biological and chemical compositions and its botanical origin,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, art. no. 697390, 2013. [Online]. Available: https://doi.org/10.1155/2013/697390

L. C. Rufatto, D. A. dos Santos, F. Marinho, J. A. P. Henriques, M. Roesch Ely, and S. Moura, “Red propolis: Chemical composition and pharmacological activity,” Asian Pacific Journal of Tropical Biomedicine, vol. 7, no. 7, pp. 591–598, 2017. [Online]. Available: https://doi.org/10.1016/j.apjtb.2017.06.009

S. Hesami, S. Hashemipour, M. R. Shiri-Shahsavar, Y. Koushan, and H. Khadem Haghighian, “Administration of Iranian propolis attenuates oxidative stress and blood glucose in type II diabetic patients: A randomized, double-blind, placebo-controlled clinical trial,” Caspian Journal of Internal Medicine, vol. 10, no. 1, pp. 48–54, 2019. [Online]. Available: https://doi.org/10.22088/cjim.10.1.48

T. Fukuda, M. Fukui, M. Tanaka, T. Senmaru, H. Iwase, M. Yamazaki, et al., “Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study,” Biomedical Reports, vol. 3, no. 3, pp. 355–360, 2015. [Online]. Available: https://doi.org/10.3892/br.2015.436

D. Majiene, S. Trumbeckaite, A. Savickas, and A. Toleikis, “Influence of propolis water solution on heart mitochondrial function,” Journal of Pharmacy and Pharmacology, vol. 58, no. 5, pp. 709–713, 2006. [Online]. Available: https://doi.org/10.1211/jpp.58.5.0017

H. Kitamura, “Effects of propolis extract and propolis-derived compounds on obesity and diabetes: Knowledge from cellular and animal models,” Molecules, vol. 24, no. 23, art. no. 4394, 2019. [Online]. Available: https://doi.org/10.3390/molecules24234394

X. P. Cao, Y. F. Chen, J. L. Zhang, M. M. You, K. Wang, and F. L. Hu, “Mechanisms underlying the wound healing potential of propolis based on its in vitro antioxidant activity,” Phytomedicine, vol. 34, pp. 76–84, 2017. [Online]. Available: https://doi.org/10.1016/j.phymed.2017.06.001

M. Medić-Sarić, V. Rastija, M. Bojić, and Z. Maleš, “From functional food to medicinal product: Systematic approach in analysis of polyphenolics from propolis and wine,” Nutrition Journal, vol. 8, art. no. 33, 2009. [Online]. Available: https://doi.org/10.1186/1475-2891-8-33

H. Chang, Y. Wang, X. Yin, X. Liu, and H. Xuan, “Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cell proliferation in an inflammatory microenvironment by inhibiting the TLR4 signaling pathway and inducing apoptosis and autophagy,” BMC Complementary and Alternative Medicine, vol. 17, art. no. 471, 2017. [Online]. Available: https://doi.org/10.1186/s12906-017-1984-9

E. T. da Cruz Almeida, M. C. D. da Silva, J. M. D. S. Oliveira, R. U. Kamiya, R. E. D. S. Arruda, D. A. Vieira, et al., “Chemical and microbiological characterization of tinctures and microcapsules loaded with Brazilian red propolis extract,” Journal of Pharmaceutical Analysis, vol. 7, no. 5, pp. 280–287, 2017. [Online]. Available: https://doi.org/10.1016/j.jpha.2017.03.004

O. M. Abo-Salem, R. H. El-Edel, G. E. Harisa, N. El-Halawany, and M. M. Ghonaim, “Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 2, pp. 205–210, 2009. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/19339239/

G. Bazmandegan, M. T. Boroushaki, A. Shamsizadeh, F. Ayoobi, E. Hakimizadeh, and M. Allahtavakoli, “Brown propolis attenuates cerebral ischemia-induced oxidative damage via affecting antioxidant enzyme system in mice,” Biomedicine & Pharmacotherapy, vol. 85, pp. 503–510, 2017. [Online]. Available: https://doi.org/10.1016/j.biopha.2016.11.057

N. Kumar, R. Dang, and A. Husain, “Antioxidant and antimicrobial activity of propolis from Tamil Nadu zone,” Journal of Medicinal Plants Research, vol. 2, pp. 361–364, 2008. [Online]. Available: https://academicjournals.org/journal/JMPR/article-abstract/2D65D9D15004

S. Narimane, E. Demircan, A. Salah, B. O. Ozcelik, and R. Salah, “Correlation between antioxidant activity and phenolic acids profile and content of Algerian propolis: Influence of solvent,” Pakistan Journal of Pharmaceutical Sciences, vol. 30, no. 4 Suppl., pp. 1417–1423, 2017. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/29084603/

J. Kocot, M. Kiełczykowska, D. Luchowska-Kocot, J. Kurzepa, and I. Musik, “Antioxidant potential of propolis, bee pollen, and royal jelly: Possible medical application,” Oxidative Medicine and Cellular Longevity, vol. 2018, art. no. 7074209, 2018. [Online]. Available: https://doi.org/10.1155/2018/7074209

V. D. Wagh, “Propolis: A wonder bees product and its pharmacological potentials,” Advances in Pharmacological Sciences, vol. 2013, art. no. 308249, 2013. [Online]. Available: https://doi.org/10.1155/2013/308249

I. L. B. Rosa, A. L. Quaresma, and G. B. Longato, “Healing potential of propolis in skin wounds evidenced by clinical studies,” Pharmaceuticals, vol. 15, no. 9, art. no. 1143, 2022. [Online]. Available: https://doi.org/10.3390/ph15091143

P. Olczyk, K. Komosinska-Vassev, G. Wisowski, L. Mencner, J. Stojko, and E. M. Kozma, “Propolis modulates fibronectin expression in the matrix of thermal injury,” BioMed Research International, vol. 2014, art. no. 748101, 2014. [Online]. Available: https://doi.org/10.1155/2014/748101

V. R. Pasupuleti, L. Sammugam, N. Ramesh, and S. H. Gan, “Honey, propolis, and royal jelly: A comprehensive review of their biological actions and health benefits,” Oxidative Medicine and Cellular Longevity, vol. 2017, art. no. 1259510, 2017. [Online]. Available: https://doi.org/10.1155/2017/1259510

H. S. Barud, A. M. de Araújo Júnior, S. Saska, L. B. Mestieri, J. A. Campos, R. M. de Freitas, et al., “Antimicrobial Brazilian propolis (EPP-AF) containing biocellulose membranes as promising biomaterial for skin wound healing,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, art. no. 703024, 2013. [Online]. Available: https://doi.org/10.1155/2013/703024

S. Silici, N. A. Koç, D. Ayangil, and S. Cankaya, “Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses,” Journal of Pharmacological Sciences, vol. 99, no. 1, pp. 39–44, 2005. [Online]. Available: https://doi.org/10.1254/jphs.FPE05002X

A. A. Berretta, M. A. D. Silveira, J. M. C. Capcha, and D. De Jong, “Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease,” Biomedicine & Pharmacotherapy, vol. 131, art. no. 110622, 2020. [Online]. Available: https://doi.org/10.1016/j.biopha.2020.110622

H. Refaat, F. M. Mady, H. A. Sarhan, H. S. Rateb, and E. Alaaeldin, “Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19,” International Journal of Pharmaceutics, vol. 592, art. no. 120028, 2021. [Online]. Available: https://doi.org/10.1016/j.ijpharm.2020.120028

M. J. Kwon, H. M. Shin, H. Perumalsamy, X. Wang, and Y.-J. Ahn, “Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds,” Journal of Apicultural Research, vol. 59, pp. 413–425, 2019. [Online]. Available: https://doi.org/10.1080/00218839.2019.1695715

A. Yildirim, G. G. Duran, N. Duran, K. Jenedi, B. S. Bolgul, M. Miraloglu, et al., “Antiviral activity of Hatay propolis against replication of herpes simplex virus type 1 and type 2,” Medical Science Monitor, vol. 22, pp. 422–430, 2016. [Online]. Available: https://doi.org/10.12659/MSM.897282

K. Cui, W. Lu, L. Zhu, X. Shen, and J. Huang, “Caffeic acid phenethyl ester (CAPE), an active component of propolis, inhibits Helicobacter pylori peptide deformylase activity,” Biochemical and Biophysical Research Communications, vol. 435, no. 2, pp. 289–294, 2013. [Online]. Available: https://doi.org/10.1016/j.bbrc.2013.04.026

I. Al-Ani, S. Zimmermann, J. Reichling, and M. Wink, “Antimicrobial activities of European propolis collected from various geographic origins alone and in combination with antibiotics,” Medicines, vol. 5, no. 1, art. no. 2, 2018. [Online]. Available: https://doi.org/10.3390/medicines5010002

S. F. Freitas, L. Shinohara, J. M. Sforcin, and S. Guimarães, “In vitro effects of propolis on Giardia duodenalis trophozoites,” Phytomedicine, vol. 13, no. 3, pp. 170–175, 2006. [Online]. Available: https://doi.org/10.1016/j.phymed.2004.07.008

A. Durazzo, M. Lucarini, M. Plutino, L. Lucini, R. Aromolo, E. Martinelli, et al., “Bee products: A representation of biodiversity, sustainability, and health,” Life, vol. 11, no. 9, art. no. 970, 2021. [Online]. Available: https://doi.org/10.3390/life11090970

V. Bankova, “Chemical diversity of propolis and the problem of standardization,” Journal of Ethnopharmacology, vol. 100, no. 1–2, pp. 114–117, 2005. [Online]. Available: https://doi.org/10.1016/j.jep.2005.05.004

R. Ahmed, E. M. Tanvir, M. S. Hossen, R. Afroz, I. Ahmmed, N. E. Rumpa, et al., “Antioxidant properties and cardioprotective mechanism of Malaysian propolis in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, art. no. 5370545, 2017. [Online]. Available: https://doi.org/10.1155/2017/5370545

V. P. Chavda, S. Vuppu, P. C. Balar, T. Mishra, R. Bezbaruah, D. Teli, et al., “Propolis in the management of cardiovascular disease,” International Journal of Biological Macromolecules, vol. 266, pt. 2, art. no. 131219, 2024. [Online]. Available: https://doi.org/10.1016/j.ijbiomac.2024.131219

N. Ohkura, Y. Takata, K. Ando, S. Kanai, E. Watanabe, T. Nohira, et al., “Propolis and its constituent chrysin inhibit plasminogen activator inhibitor 1 production induced by tumour necrosis factor-α and lipopolysaccharide,” Journal of Apicultural Research, vol. 51, no. 2, pp. 179–184, 2012. [Online]. Available: https://doi.org/10.3896/IBRA.1.51.2.06

J. Gwak, J. Oh, M. Cho, S. K. Bae, I. S. Song, K. H. Liu, et al., “Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation,” Molecular Pharmacology, vol. 79, no. 6, pp. 1014–1022, 2011. [Online]. Available: https://doi.org/10.1124/mol.110.069591

H. Xuan, Z. Li, H. Yan, Q. Sang, K. Wang, Q. He, et al., “Antitumor activity of Chinese propolis in human breast cancer MCF-7 and MDA-MB-231 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, art. no. 280120, 2014. [Online]. Available: https://doi.org/10.1155/2014/280120

G. C. Chan, K. W. Cheung, and D. M. Sze, “The immunomodulatory and anticancer properties of propolis,” Clinical Reviews in Allergy & Immunology, vol. 44, no. 3, pp. 262–273, 2013. [Online]. Available: https://doi.org/10.1007/s12016-012-8322-2

E. Forma and M. Bryś, “Anticancer activity of propolis and its compounds,” Nutrients, vol. 13, no. 8, art. no. 2594, 2021. [Online]. Available: https://doi.org/10.3390/nu13082594

F. Li, S. Awale, Y. Tezuka, and S. Kadota, “Cytotoxicity of constituents from Mexican propolis against a panel of six different cancer cell lines,” Natural Product Communications, vol. 5, no. 10, pp. 1601–1606, 2010. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/21121236/

S. Demir, Y. Aliyazicioglu, I. Turan, S. Misir, A. Mentese, S. O. Yaman, et al., “Antiproliferative and proapoptotic activity of Turkish propolis on human lung cancer cell line,” Nutrition and Cancer, vol. 68, no. 1, pp. 165–172, 2016. [Online]. Available: https://doi.org/10.1080/01635581.2016.1115096

A. Kabała-Dzik, A. Rzepecka-Stojko, R. Kubina, Ż. Jastrzębska-Stojko, R. Stojko, R. D. Wojtyczka, et al., “Comparison of two components of propolis: Caffeic acid (CA) and caffeic acid phenethyl ester (CAPE) induce apoptosis and cell cycle arrest of breast cancer cells MDA-MB-231,” Molecules, vol. 22, no. 9, art. no. 1554, 2017. [Online]. Available: https://doi.org/10.3390/molecules22091554

T. Wan, Z. Wang, Y. Luo, Y. Zhang, W. He, Y. Mei, et al., “FA-97, a new synthetic caffeic acid phenethyl ester derivative, protects against oxidative stress-mediated neuronal cell apoptosis and scopolamine-induced cognitive impairment by activating Nrf2/HO-1 signaling,” Oxidative Medicine and Cellular Longevity, vol. 2019, art. no. 8239642, 2019. [Online]. Available: https://doi.org/10.1155/2019/8239642

J. Ni, Z. Wu, J. Meng, A. Zhu, X. Zhong, S. Wu, and H. Nakanishi, “The neuroprotective effects of Brazilian green propolis on neurodegenerative damage in human neuronal SH-SY5Y cells,” Oxidative Medicine and Cellular Longevity, vol. 2017, art. no. 7984327, 2017. [Online]. Available: https://doi.org/10.1155/2017/7984327

K. Boutabet, W. Kebsa, M. Alyane, and M. Lahouel, “Polyphenolic fraction of Algerian propolis protects rat kidney against acute oxidative stress induced by doxorubicin,” Indian Journal of Nephrology, vol. 21, no. 2, pp. 101–106, 2011. [Online]. Available: https://doi.org/10.4103/0971-4065.82131

A. Salatino, C. C. Fernandes-Silva, A. A. Righi, and M. L. F. Salatino, “Propolis research and the chemistry of plant products,” Natural Product Reports, vol. 28, no. 5, pp. 925–936, 2011. [Online]. Available: https://doi.org/10.1039/C0NP00072H

N. Zabaiou, A. Fouache, A. Trousson, S. Baron, A. Zellagui, M. Lahouel, and J. A. Lobaccaro, “Biological properties of propolis extracts: Something new from an ancient product,” Chemistry and Physics of Lipids, vol. 207, pt. B, pp. 214–222, 2017. [Online]. Available: https://doi.org/10.1016/j.chemphyslip.2017.04.005

A. R. Torres, L. P. Sandjo, M. T. Friedemann, M. M. Tomazzoli, M. Maraschin, C. F. Mello, et al., “Chemical characterization, antioxidant and antimicrobial activity of propolis obtained from Melipona quadrifasciata quadrifasciata and Tetragonisca angustula stingless bees,” Brazilian Journal of Medical and Biological Research, vol. 51, no. 6, art. no. e7118, 2018. [Online]. Available: https://doi.org/10.1590/1414-431X20187118

M. El-Sakhawy, A. Salama, and H. S. Tohamy, “Applications of propolis-based materials in wound healing,” Archives of Dermatological Research, vol. 316, art. no. 61, 2023. [Online]. Available: https://doi.org/10.1007/s00403-023-02789-x

M. F. Tolba, S. S. Azab, A. E. Khalifa, S. Z. Abdel-Rahman, and A. B. Abdel-Naim, “Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: A review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects,” IUBMB Life, vol. 65, no. 8, pp. 699–709, 2013. [Online]. Available: https://doi.org/10.1002/iub.1189

K. Pobiega, K. Kraśniewska, and M. Gniewosz, “Application of propolis in antimicrobial and antioxidative protection of food quality: A review,” Trends in Food Science & Technology, vol. 83, pp. 53–62, 2019. [Online]. Available: https://doi.org/10.1016/j.tifs.2018.11.007

S. El-Guendouz, B. Lyoussi, and M. G. Miguel, “Insight on propolis from Mediterranean countries: Chemical composition, biological activities and application fields,” Chemistry & Biodiversity, vol. 16, no. 7, art. no. e1900094, 2019. [Online]. Available: https://doi.org/10.1002/cbdv.201900094

I. A. Freires, S. M. de Alencar, and P. L. Rosalen, “A pharmacological perspective on the use of Brazilian red propolis and its isolated compounds against human diseases,” European Journal of Medicinal Chemistry, vol. 110, pp. 267–279, 2016. [Online]. Available: https://doi.org/10.1016/j.ejmech.2016.01.033

A. H. Banskota, Y. Tezuka, and S. Kadota, “Recent progress in pharmacological research of propolis,” Phytotherapy Research, vol. 15, no. 7, pp. 561–571, 2001. [Online]. Available: https://doi.org/10.1002/ptr.1029

A. Salatino, “Perspectives for uses of propolis in therapy against infectious diseases,” Molecules, vol. 27, no. 14, art. no. 4594, 2022. [Online]. Available: https://doi.org/10.3390/molecules27144594

N. Ripari, A. A. Sartori, M. da S. Honorio, F. L. Conte, K. I. Tasca, K. B. Santiago, et al., “Propolis antiviral and immunomodulatory activity: A review and perspectives for COVID-19 treatment,” Journal of Pharmacy and Pharmacology, vol. 73, no. 3, pp. 281–299, 2021. [Online]. Available: https://doi.org/10.1093/jpp/rgaa067

G. A. Burdock, “Review of the biological properties and toxicity of bee propolis,” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998. [Online]. Available: https://doi.org/10.1016/S0278-6915(97)00145-2

R. Chen, J. Lin, J. Hong, D. Han, A. D. Zhang, R. Lan, et al., “Potential toxicity of quercetin: The repression of mitochondrial copy number via decreased POLG expression and excessive TFAM expression in irradiated murine bone marrow,” Toxicology Reports, vol. 1, pp. 450–458, 2014. [Online]. Available: https://doi.org/10.1016/j.toxrep.2014.07.014

S. Castaldo and F. Capasso, “Propolis, an old remedy used in modern medicine,” Fitoterapia, vol. 73, suppl. 1, pp. S1–S6, 2002. [Online]. Available: https://doi.org/10.1016/S0367-326X(02)00185-5

S. I. Anjum, A. Ullah, K. A. Khan, M. Attaullah, H. Khan, H. Ali, et al., “Composition and functional properties of propolis (bee glue): A review,” Saudi Journal of Biological Sciences, vol. 26, no. 7, pp. 1695–1703, 2019. [Online]. Available: https://doi.org/10.1016/j.sjbs.2018.08.013

E. W. Teixeira, D. Message, G. Negri, A. Salatino, and P. C. Stringheta, “Seasonal variation, chemical composition and antioxidant activity of Brazilian propolis samples,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 307–315, 2010. [Online]. Available: https://doi.org/10.1093/ecam/nem177

D. Kasote, V. Bankova, and A. M. Viljoen, “Propolis: Chemical diversity and challenges in quality control,” Phytochemistry Reviews, vol. 21, no. 6, pp. 1887–1911, 2022. [Online]. Available: https://doi.org/10.1007/s11101-022-09816-1

P. P. Wieczorek, N. Hudz, O. Yezerska, V. Horčinová-Sedláčková, M. Shanaida, O. Korytniuk, and I. Jasicka-Misiak, “Chemical variability and pharmacological potential of propolis as a source for the development of new pharmaceutical products,” Molecules, vol. 27, no. 5, art. no. 1600, 2022. [Online]. Available: https://doi.org/10.3390/molecules27051600




DOI: https://doi.org/10.37311/ijpe.v6i2.38139

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Ahlam Omer, Shelan Rasool, Hazhmat Ali

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.